All lobbying filings

DH DIAGNOSTICS LLC

Lobbying for DH DIAGNOSTICS, LLC · Diagnostics manufacturers

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $250,000.00 expenses · posted Apr 20, 2026

Official filing document

Bills named in this filing 8

HR 7352
PASTEUR Act of 2026
S 1941
Cure Hepatitis C Act of 2025
S 2761
RESULTS Act
HR 5269
RESULTS Act
S 1399
Health Tech Investment Act
HR 6197
Health Tech Investment Act
S 3287
Fair Allocation of Interstate Rates Act
HR 6130
ASAP Act

Lobbying activity 3

Health Issues

Issues related to diagnostic testing, Oncology, Hepatitis C funding H.R.7352, the Pioneering Antimicrobial Subscriptions To End Upsurging Resistence Act of 2026 (PASTEUR Act) S.1941, the Cure Hepatitis C Act of 2025

Medicare/Medicaid

Issues related to diagnostic testing, Oncology and the Reforming and Enhancing Sustainable Updates to Laboratory Services (the RESULTS Act, S.2761/H.R. 5269). S.1399/H.R.6197, the Health Tech Investment Act S.3287/H.R.6130, Alzheimer's Screening and Prevention (ASAP) Act

Budget/Appropriations

Funding for diagnostics

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.